Search:
Climacteric Editorial Board
Editor-in-Chief

Rod Baber is the immediate Past President and an Honorary Member of The International Menopause Society and Clinical Professor of Obstetrics and Gynaecology at Sydney Medical School, The University of Sydney.

He is a past President and Life member of The Australasian Menopause Society, a fellow of both The Royal College of Obstetricians and Gynaecologists and The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

He is an associate editor of The ANZ Journal of Obstetrics and Gynaecology.

He is head of The Menopause and Menstrual disorders unit at The Royal North Shore Hospital in Sydney as well as conducting a private clinical practice in obstetrics and gynaecology in Sydney.

He has had a career long interest in reproductive endocrinology, is widely published and is a regular speaker at national and international meetings.

 

Professor Baber has disclosed that, via hospital and university administered trust accounts, he has received research grants from Wyeth, Novartis, Organon, Upjohn, Bayer Schering, Proctor & Gamble, Pfizer and Novogen. He has served on speakers’ bureaux for Wyeth, Organon, Bayer Schering and Novo Nordisk. He has served on medical advisory boards for Servier and Wyeth. He currently holds no positions on medical advisory boards or speakers’ bureaux.

Associate Editors
Peter Chedraui

Peter Chedraui  is an Obstetrician and Gynecologist, Associate professor  and Director of the Institute of  Biomedicine of the Universidad Católica de Santiago de Guayaquil, Guayaquil, Ecuador.

He is Past President of the Ecuadorian Climacteric and Menopause Society, member of several international scientific society boards of which he has served two full periods for the International Menopause Society. 

His field of expertise is women's health, focused specifically on the menopause and its effect on weight, inflammation and the metabolism of ageing women, endorsed by more than 150 peer reviewed publications, many of which are part of a joint effort of a Latin American scientific network.

 

Tim Hillard

Tim Hillard is a Consultant Obstetrician & Gynaecologist at Poole Hospital, Dorset, UK. He graduated from Southampton University and subsequently worked at King's College Hospital, London where he  developed his interest in menopause and completed his MD on transdermal HRT and osteoporosis. He runs one of the few specialist menopause clinics in the South of England outside London and also heads a busy uro-gynaecology department.

He is a past Chairman and current trustee of the British Menopause Society. He is the immediate past secretary of the British Uro-gynaecology Society and is a patron of the Daisy network (a UK charity for women with premature ovarian insufficiency). He has lectured and published widely on various aspects of the menopause and uro-gynaecology.

 

Tim Hillard has disclosed that he has received educational grants and sponsorship to attend meetings from Astellas, Bayer Schering, Besins Healthcare, Novo Nordisk and Speciality European Pharma. He has received speaker fees from Astellas, Bayer Schering, Mylan and Pfizer. He has acted as a paid advisory board member to Consilient Health and Novo Nordisk. He has no active participation or any financial interest in any of these companies.

James H Pickar

James H. Pickar is a fellow of the American College of Obstetrics and Gynecology and an Adjunct Associate Professor of Obstetrics and Gynecology at Columbia University College of Physicians and Surgeons.  

He has over 80 publications, is a Senior Editorial Advisor for Maturitas, and serves as a reviewer for multiple scientific journals.  He has also served on the board of the International Menopause Society and the Scientific Advisory Board of the International Symposium on Hormonal Carcinogenesis.  

Dr. Pickar was the 2013 recipient of the NAMS/Thomas B. Clarkson Outstanding Clinical & Basic Science Research Award and is a member of numerous professional and scientific organizations.

 

Dr Pickar has disclosed that he has consulted for Wyeth/Pfizer, Radius Health Inc, Shionogi Inc, and TherapeuticsMD; and has stock options with TherapeuticsMD.

Tevfik Yoldemir

Tevfik Yoldemir is Professor of Obstetrics and Gynaecology at the Medical School of Marmara University, Istanbul, Turkey. He is a member of the Turkish Menopause and Osteoporosis Society, Turkish Urogynecology and Pelvic Reconstructive Surgery Association, Turkish Society of Reproductive Medicine, Pelvic Pain and Endometriosis Association and the Gynecologic and Obstetric Ultrasonography Association.

He is a member of the editorial board of the Marmara Medical Journal and he is the medical director of ART Unit and a full-time consultant in obstetrics and gynaecology clinic at the Marmara University Hospital in Istanbul.

His fields of interest are reproductive endocrinology, assisted reproductive technologies, endometriosis surgery, minimally invasive gynecologic surgery, pelvic floor reconstruction.

 

Professor Yoldemir has no conflict of interest or disclosures

Qi Yu

Qi YU is the president of the Chinese Menopause society and the clinical professor of Reproductive Endocrinology in Peking Union Medical College Hospital. 

He is now the Deputy Director of the O&G Dept. in PUMC hospital and the Director of the assistant reproductive center.

He is the Editorial board member of Chinese Journal of Obstetrics and Gynecology, Chinese Journal of Osteoporosis and Bone Mineral Disease, Journal of Reproductive Medicine, Chinese Journal of Clinical Obstetrics and Gynecology, Journal of Practical Obstetrics and Gynecology, Chinese Journal of Practical Gynecology and Obstetrics.

He is experienced in diagnosis and treatment of gynecological endocrinology diseases with abundant publications and served as a regular speaker in this field.

 

Dr Yu has disclosed that he is the recipient of sponsorship funding to attend meetings on behalf of and is a member of the speakers’ bureaux for Bayer, Merck, Wyeth, Solvay and MSD; he is a recipient of research/grant funding from Eli-Lilly, Merck, Bayer and Daiichi Sankyo.

Editorial Board
Mr Farook Al-Azzawi, MA(Cantab), PhD, FRCOG (United Kingdom)

Consultant Gynaecologist, Leicester Royal Infirmary, Leicester, UK
Mr Al-Azzawi has disclosed that he has received through the University of Leicester and through the R&D office of the University Hospitals of Leicester educational grants and sponsorship funding to attend meetings on behalf of Procter & Gamble, Servier, Solvay Pfizer, Novo-Nordisk, Schering, Upjohn Novartis, Organon, Bayer, AbbVie, Schering and Wyeth.

Dr Peter Alexandersen, MD (Denmark)

Center for Clinical and Basic Research (CCBR), Denmark
Dr Alexandersen has no conflict of interest or disclosures.

Professor Henry Burger, AO, MD, FRCP, FRACP, FCP (SA), FRCOG, FRANZCOG, FAA, FAHMS (Australia)

Emeritus Director, Prince Henry’s Institute of Medical Research, Consultant Endocrinologist, Jean Hailes Foundation for Women’s Health and Adjunct Professorial Fellow, Monash University, Melbourne, Australia.
Professor Burger has disclosed that he has served on Advisory Boards and/or acted as a symposium or dinner speaker for Schering Plough (formerly Organon), Novo Nordisk, Bayer Schering Pharma, Pfizer and Wyeth. He has no financial interests in these or other pharmaceutical companies.

Professor Camil Castelo-Branco, MD, PhD (Spain)

Professor of Gynecology & Obstetrics, University of Barcelona; Senior Consultant Physician, Clinic Institute of Gynecology, Obstetrics & Neonatology; Hospital Clínic, Barcelona, Spain
Professor Castelo-Branco has disclosed that he is a recipient of research/grant funding from Shionogi, is a consultant/advisor to and is a member of the speakers’ bureaux for: Pierre-Fabre (Sp), Shionogi (Sp), MSD (Sp), Isdin

Dr Aila Collins, PhD (Sweden)

Associate Professor at the Section of Psychology, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
Professor Collins has no conflict of interest or disclosures.

Professor Susan R Davis, MB BS, FRACP, PhD (Australia)

Women’s Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne Australia 
Professor Davis has disclosed that she has received honoraria from Besins Healthcare, Abbott Australia and Pfizer and has research grant support from the National Health and Medical Research Council of Australia, the National Breast Cancer Foundation and Lawley Pharmaceuticals.

Dr Tobie J de Villiers, MBChB, MMed(O&G), MRCOG, FCOG(SA) (South Africa)

Consultant Gynaecologist, Panorama MediClinic and Department of Obstetrics & gynecology, University of Stellenbosch, Cape Town, South Africa
Dr de Villiers has served as speaker or consultant to Amgen, Abbott, Adcock Ingram, Aspen, Bayer, CIPLA, Merck and Pfizer.

Dr Anna Fenton, BHB, MBChB, PhD, FRACP (New Zealand)

Endocrinologist, Christchurch Women's Hospital, University of Otago School of Medicine, Christchurch, New Zealand
Dr Fenton has disclosed that she has been a member of the Speakers’ Bureau for Pfizer and a member of the PTAC Endocrine sub-committee, Pharmac, New Zealand.

Professor Marco Gambacciani (Italy)

Department of Obstetrics & Gynecology, Ospedale S. Chiara, University of Pisa, Pisa, Italy
Professor Gambacciani has no conflict of interest or disclosures

Professor Ulysse Gaspard, MD, PhD (Belgium)

Honorary Professor and Head, Department of Gynaecology, Sart Tilman University Hospital, University of Liege, Liege, Belgium; Senior Consultant Physician, University Clinics L.Brull, University of Liege, Belgium
Professor Gaspard has disclosed that he is a consultant/advisor to Mithra Pharmaceuticals

Professor Andrea Genazzani (Italy)

Professor of Gynecology and Obstetrics, University of Pisa; President of the International Society of Gynecological Endocrinology (ISGE); President of the European Society of Gynecology (ESG); General Secretary of the International Academy of Human Reproduction (IAHR); Editor-in-Chief of Gynecological Endocrinology
Professor Genazzani has no conflict of interest or disclosures.

Professor Steven R Goldstein, MD (USA)

Professor of Obstetrics and Gynecology, New York University School of Medicine; Director of Gynecologic Ultrasound; Co-Director of Bone Densitometry, New York University Langone Medical Center, New York, USA
Professor Goldstein has disclosed that he is on the Gyn Advisory Board for AbbVie, Allergan, IBSA, Pfizer, and Therapeutics MD; is a consultant for Cook ObGyn, Cooper Surgical and Philips Ultrasound.

Professor Anne Gompel, MD, PhD (France)

Head of the Gynecology Endocrinology Unit, Port Royal -Cochin , Paris; Professor of Reproductive Endocrinology, Paris Descartes University, member of the INSERM UMRS 1007 Les Saints Pères, Paris , France
Professor Gompel has disclosed that she is a recipient of research/grant funding from HRA Pharma. She contributes to the Advisory board of MITHRA for Estetrol, Behring for Berinert and Shire for Icatibant.

Professor Franco Guidozzi (South Africa)
Prof. Dr. med. Peyman Hadji (Germany)

Professor Hadji has disclosed that, via hospital and university administered trust accounts, he has received research grants, has served on speakers’ bureaux and attended at medical Advisory Boards for Amgen, Astra Zeneca, Eli Lilly, Novartis, Madaus, Pfizer, Roche, Novo Nordisk, and Proctor & Gamble.

Dr Christopher J. Haines MBBS, MD. FRANZCOG, FHKAM (O&G) (Australia)

Professor, Department of Obstetrics and Gynaecology, Flinders Reproductive Medicine, Flinders University, South Australia, Australia
Professor Haines has disclosed that he has no existing conflicts of interest.

Professor Victor W Henderson, MD, MS (USA)

Professor of Health Research & Policy (Epidemiology) and of Neurology & Neurological Science, Stanford University, Stanford, California, USA
Professor Henderson has disclosed that he is a recipient of research/grant funding from the National Institutes of Health.

Professor Elaine Jolly (Canada)
Dr Beverly Lawton (New Zealand)
Professor Marc LHermite, MD, PhD, DSci (Belgium)

Honorary Professor of the Université Libre de Bruxelles, Emeritus Head of Obstetrics & Gynecology Department of Brugmann Hospital, Brussels, Belgium 
Professor L'Hermite has disclosed that he has been in the past the recipient of research/grant/congress travel funding from Besins, Farmitalia/Pharmacia, Organon, Sandoz, Solvay and Wyeth/Ayerst; and is presently a sporadic consultant to Besins.

Professor Rogerio A Lobo, MD, FACOG (USA)

Professor of Obstetrics and Gynecology, Columbia University, New York, New York
Professor Lobo has disclosed research funding from TherapeuticsMD; Consultant to TherapeuticsMD, AMAG, JDS Therapeutics, Pfiser, Allergan, Teva and Mithra.

Professor Mary Ann Lumsden (United Kingdom)

Head of Section, Reproductive and Maternal Medicine, University of Glasgow, Royal Infirmary, Glasgow, UK
Professor Lumsden has nothing to disclose.

Miss JoAnn Marsden (UK)

Consultant Breast Surgeon, King's Breast Care, King's College Hospital NHS Foundation Trust, Denmark Hill, London, UK

Professor Alfred O Mueck, MD, PharmD, PhD (Germany)

Professor of Clinical Pharmacology and Experimental Endocrinology, Head of Centre of Women’s Health South Germany (BW), Medical Director of Department of Endocrinology and Menopause; University Women’s Hospital of Tuebingen, Germany
Professor Mueck has disclosed that he is a consultant/advisor to Bayer-Schering, Novartis, Novo Nordisk, Procter & Gamble, Schering-Plough/Merck Sharpe & Dohme and Solvay and is also a member of the speakers’ bureaux of these companies. He is a recipient of research/grant funding from Bayer-Schering, Dr.Kade Pharma, Novartis, Novo Nordisk and Schering-Plough/Merck Sharpe & Dohme.

Professor Rossella Nappi MD, PhD (Italy)

Research Center for Reproductive Medicine, Gynaecological Endocrinology and Menopause, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy
Professor Nappi has disclosed that, during the past 2 years, she has had financial relationships with Bayer, Endoceutics, Gedeon Richter, HRA Pharma, MSD, Novo Nordisk, Pfizer, Shionogi, and Teva.

Dr Santiago Palacios, MD, PhD (Spain)

Director of the Palacios Institute of Women’s Health, Madrid, Spain
Dr Palacios has disclosed that he is a recipient of research/grant funding from, is a consultant/advisor to, and/or is a lecturer for: Abbott, Amgen, Bayer Healthcare, Bioiberica, Exeltis, Ferrer, Gedeon Richter, GSK, Gynea, MSD, Novo Nordisk, Pfizer, Preglem, Procare Health, Sandoz, Serelys, Servier, Shionogi and Teva.

Mr Nick Panay, BSc, MRCOG, MFSRH (United Kingdom)

Queen Charlotte’s & Chelsea Hospital, London, UK
Mr Panay has disclosed that he has acted in an advisory capacity, performed research and/or lectured on behalf of the following companies: Baxter, Bayer Schering, Eli Lilly, Galen, Janssen Cilag, Merck, Novo Nordisk, Novogen, Organon, Orion, Procter & Gamble, Se-cure, Servier, Shire, Solvay, Storz, and Wyeth.

Professor Faustino R Perez-Lopez (Spain)

Head of Gynecology Department, Lozano-Blesa University Hospital, and Professor of Obstetrics and Gynecology, University of Zaragoza Faculty of Medicine, Zaragoza, Spain
Professor Perez-Lopez has nothing to disclose.

Professor Amos Pines (Israel)

Specialist in Internal Medicine, working in the Tel-Aviv Medical Center, which is affiliated to the Tel-Aviv University School of Medicine
Professor Pines has disclosed that he has no conflict of interest, except for an indirect one, being a consultant for a local, Israeli distributor that represents about 20 international pharma companies with niche products in all fields of medicine

Professor JoAnn Pinkerton, MD (USA)

Professor of Obstetrics and Gynecology, Director, Midlife Health Division, University of Virginia, Charlottesville, Virginia, USA and Executive Director of North American Menopause Society
Professor Pinkerton has disclosed that she has been Consultant (fees to University of Virginia Health System) for Pfizer, received grants/research support from TherapeuticsMD; received travel funds for consulting from Pfizer, and editorial in kind (no fees) writing support from Pfizer, TherapeuticsMD, Shionogi, and Noven Pharmaceuticals

Professor Giuseppe M. C. Rosano, MD, PhD (Italy)

Director, Centre for Clinical & Basic Research, IRCCS San Raffaele Roma, Rome, Italy
Professor Rosano has nothing to disclose.

Professor Serge Rozenberg, MD (Belgium)

Professor of Obstetrics and Gynaecology, Université Libre de Bruxelles (Free University Brussels), Belgium
Professor Rozenberg has disclosed that he is a recipient of research grant of IRIS- King Baudouin Fondation, Vesale research Foundation, Gedeon, Mthra, Amgen, Speakers bureau /member of the advisory boards of Amgem, and Merck Sharpe & Dohme, Abbot, Pfizer, Will, Gedeon Richter, Serylis Pharma

Professor Hermann P G Schneider, MD, PhD, FRAM (Germany)

Emeritus Professor of Obstetrics & Gynecology, Department of Obstetrics & Gynecology, University of Muenster Medical School, Muenster, Germany
Professor Schneider has nothing to disclose.

Dr Duru Shah MD, FRCOG, FCPS, FICS, FICOG, FICMCH, DGO, DFP (India)

Past Professor Obstetrics & Gynecology, Grant Medical College, Nowrosjee Wadia Maternity Hospital, University of Mumbai. Post Graduate Guide for Diplomate of National Board, Jaslok Hospital & Research Center, Mumbai, India
Dr Shah has disclosed that she is on the Advisory Board for Pfizer (India), Bayer Zydus (India), Abbott (India), Sanofi Aventis (India) and a member of the Speakers Bureau for these Corporates. She is also on the Board of Directors of Metropolis Healthcare.

Dr Marla Shapiro C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP (Canada)

Professor, Department of Family and Community Medicine, University of Toronto; Medical Consultant CTV News Canada
Dr Marla Shapiro has disclosed that she is on Advisory Boards for Amgen, Merck, GSK, and Pfizer, and has received Speaker Honoraria from Merck, Amgen, Pfizer, Novo Nordisk, and Allergan.

Professor Lee P Shulman (USA)
Dr John C Stevenson, MB BS, FRCP, FESC, MFSEM (United Kingdom)

Reader and Consultant Metabolic Physician/Honorary Principal Research Fellow, National Heart & Lung Institute, Imperial College London, Royal Brompton Hospital, London, UK
Dr Stevenson has disclosed that he is the recipient of research/grant funding from Mylan and Pfizer; and lecturer for Abbott, Gedeon Richter, Menarini and Mylan.

Professor John W W Studd, DSc, MD, FRCOG (United Kingdom)

Professor of Gynaecology, London PMS and Menopause Centre, London, UK
Professor Studd has disclosed that, since retiring from the NHS and the University 4 years ago, he has received no research funding but remains on the advisory board of Procter & Gamble.

Professor Cynthia Stuenkel (USA)

University of California at San Diego, La Jolla, California, USA

Dr David W Sturdee, MB BS, MD, DA, FRCOG (United Kingdom)

Hon Consultant Gynecologist/Hon Senior Clinical Lecturer, Heart of England NHS Foundation Trust at Solihull Hospital and University of Birmingham, UK
Dr Sturdee has disclosed that he is not currently in receipt of any research grant, but is a consultant/advisor to Novo Nordisk and has lectured on behalf of Aspen Holdings at the Prague Congress.

Dr D A Tan, MD, FPOGS, FPSREI, FPSGE (Philippines)

Head, Section of Reproductive Medicine, Department of Obstetrics and Gynecology, St. Luke’s Medical Center-Quezon City, Quezon City, Philippines
Dr Tan has disclosed that he currently serves in the Advisory Boards for Bayer Healthcare Pharmaceuticals, Vifor Pharma, and Biofemme Philippines. He has received research grants from Bayer Pharmaceutical and sponsorships to attend medical meetings from Bayer Healthcare Pharmaceuticals, Vifor Pharma and Biofemme Philippines. He gives lectures for Bayer Healthcare Pharmaceuticals, Vifor Pharma, Biofemme Philippines, and Menarini Pharma.

Dr Lian G Ulrich, MD, Dip.Pharm Med. (UK), Gynaecologist and Obstetrician (DK) (Denmark)

Consultant at the Department of Obstetrics and Gynecology, Gynaecological Oncology Subgroup, Copenhagen University Hospital ‘Rigshospitalet’, Copenhagen, Denmark
Dr Ulrich has disclosed that she has received speaker’s fees and is a member of the Organon-Schering Plough-MSD Danish advisory board. She has also received speaker’s fees from Novo Nordisk and reimbursement of travelling expenses when speaking for Novo Nordisk in Europe. She and her husband own a small amount of stock in Novo Nordisk.

Professor Wulf Utian MB BCh, PhD, DSc(Med), FRCOG, FACOG, FICS (USA)

Honorary Founding President and Exec. Director Emeritus, NAMS; Chair Scientific Board, RMR Inc.; Professor Emeritus, Case Western Reserve University; Consultant, Gynecology and Women¹s Health, The Cleveland Clinic; Founder and Honorary Past President, International Menopause Society
Professor Utian has disclosed that he has acted as Consultant/Advisory Board to Pharmavite, Endoceutics, Mithra, and PulseNmore

Professor Paulina Villaseca (Chile)

Associate Professor, Gynecologist, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Professor Villaseca has disclosed that she has participated in Advisory Boards for Novo Nordisk and Amgen

Dr Amanda Vincent MBBS, B Med Sci (Hons), PhD, FRACP (Australia)

Consultant Endocrinologist, Menopause Unit, Southern Health, Monash Medical Centre, Clayton, Victoria, Australia; Senior Post-doctoral Research Fellow, Jean Hailes Foundation Clinical Research Unit, School of Public Health and Preventative Medicine, Monash University, Clayton, Victoria, Australia
Dr Vincent has disclosed that she is the recipient of research/grant funding from Organon and Ralph Lauren and has been a member of the speakers’ bureau for Organon

Sheryl Kingsberg PhD (USA)